JAMP-HYDRALAZINE
Identification of Jamp-Hydralazine
| No description |
Google image searchProduct monograph
Active ingredient
hydralazine hydrochloride, 25 MG
DIN: 02457873
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 28-AUG-2017
ATC:
- C02 — ANTIHYPERTENSIVES (ATC, ATC/DDD, )
- C02D — ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON (ATC, ATC/DDD)
- C02DB — Hydrazinophthalazine derivatives (ATC, ATC/DDD)
- C02DB02 — HYDRALAZINE (ATC/DDD)
Reference brand drug: Apresoline
Pharmaceutical standard: USP
